Thousands of Avandia Suits Settled for $250 Million, Sources Say
Lawyers USA › February 15, 2011
Linked as:
Summary
GlaxoSmithKline has agreed to pay more than $250 million to resolve about 5,500 claims related to its diabetes drug Avandia, reports Bloomberg, citing information from two individuals close to the accords.
However, Bernadette King, GlaxoSmithKline's Director of Product Communications, told Lawyers USA that she could not confirm the amount of the settlement or the number of plaintiffs involved.See the full content of this document
Extract
Thousands of Avandia Suits Settled for $250 Million, Sources Say
In an e-mail, she...
See the full content of this document
Sponsored links
